628 related articles for article (PubMed ID: 16271957)
41. [Application of dual-color fluorescence in situ hybridization in acute myeloid leukemia with t (8; 21)].
Li CW; Bo LJ; Dai Y; Liu XP; Qin S; Liu SH; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):32-5. PubMed ID: 16732938
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia.
Rodrigues PC; Oliveira SN; Viana MB; Matsuda EI; Nowill AE; Brandalise SR; Yunes JA
Pediatr Blood Cancer; 2007 Aug; 49(2):133-8. PubMed ID: 16883592
[TBL] [Abstract][Full Text] [Related]
43. Shifts in expression of immunological cell markers in relapsed acute leukemia.
Tomová A; Babusíková O
Neoplasma; 2001; 48(3):164-8. PubMed ID: 11583283
[TBL] [Abstract][Full Text] [Related]
44. [Biphenotypic acute leukaemia with Burkitt-like cytology].
Coche D; Bergues B; Harrivel V; Guillaume N
Ann Biol Clin (Paris); 2009; 67(4):437-40. PubMed ID: 19654084
[TBL] [Abstract][Full Text] [Related]
45. Immunophenotypic challenges in diagnosis of CD79a negativity in a patient with B acute lymphoblastic leukemia harboring intrachromosomal amplification of chromosome 21: a case report.
Berhili A; Bensalah M; ElMalki J; Elyagoubi A; Seddik R
J Med Case Rep; 2021 Oct; 15(1):531. PubMed ID: 34706776
[TBL] [Abstract][Full Text] [Related]
46. Biphenotypic acute leukemia with coexpression of CD79a and markers of myeloid lineage.
Frater JL; Yaseen NR; Peterson LC; Tallman MS; Goolsby CL
Arch Pathol Lab Med; 2003 Mar; 127(3):356-9. PubMed ID: 12653584
[TBL] [Abstract][Full Text] [Related]
47. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2.
Ahmad F; Kokate P; Chheda P; Dalvi R; Das BR; Mandava S
Cancer Genet Cytogenet; 2008 Jan; 180(2):153-7. PubMed ID: 18206543
[TBL] [Abstract][Full Text] [Related]
48. [Immunophenotypic analysis in acute leukemia].
Akashi K; Harada M
Nihon Rinsho; 1992 Jun; 50(6):1229-35. PubMed ID: 1518138
[TBL] [Abstract][Full Text] [Related]
49. Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring.
Langebrake C; Brinkmann I; Teigler-Schlegel A; Creutzig U; Griesinger F; Puhlmann U; Reinhardt D
Cytometry B Clin Cytom; 2005 Jan; 63(1):1-9. PubMed ID: 15624201
[TBL] [Abstract][Full Text] [Related]
50. Clonality analysis of cell lineages in acute myeloid leukemia with inversion 16.
Chang H; Nayar R; Li D; Sutherland DR
Cancer Genet Cytogenet; 2005 Jan; 156(2):175-8. PubMed ID: 15642400
[TBL] [Abstract][Full Text] [Related]
51. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
Zelezníková T; Babusíková O
Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719
[TBL] [Abstract][Full Text] [Related]
52. Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the t(8;21) chromosomal translocation in pediatric acute myeloid leukemia.
Pearson L; Leith CP; Duncan MH; Chen IM; McConnell T; Trinkaus K; Foucar K; Willman CL
Leukemia; 1996 Aug; 10(8):1274-82. PubMed ID: 8709631
[TBL] [Abstract][Full Text] [Related]
53. Acute myeloid leukemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies: a report of four cases and review of the literature.
Huang L; Abruzzo LV; Valbuena JR; Medeiros LJ; Lin P
Am J Clin Pathol; 2006 Feb; 125(2):267-72. PubMed ID: 16393685
[TBL] [Abstract][Full Text] [Related]
54. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
55. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
[TBL] [Abstract][Full Text] [Related]
56. Molecular cytogenetic investigations in a novel complex variant of t(8;21)(q22;q22) with ins(15;21)(q15;q22.2q22.3) in a patient with AML-M2 subtype.
Kokate P; Ahmad F; Dalvi R; Das BR; Mandava S
Cancer Genet Cytogenet; 2008 Jul; 184(1):52-6. PubMed ID: 18558290
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of complete disease remission in acute myeloid leukemia: a prospective study based on cytomorphology, interphase fluorescence in situ hybridization, and immunophenotyping during follow-up in patients with acute myeloid leukemia.
Bacher U; Kern W; Schoch C; Schnittger S; Hiddemann W; Haferlach T
Cancer; 2006 Feb; 106(4):839-47. PubMed ID: 16419072
[TBL] [Abstract][Full Text] [Related]
58. Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia.
Kraguljac N; Marisavljevic D; Jankovic G; Radosevic N; Pantic M; Donfrid M; Miletic N; Boskovic D; Colovic M
Am J Clin Pathol; 2000 Jul; 114(1):29-34. PubMed ID: 10884796
[TBL] [Abstract][Full Text] [Related]
59. [Study on the clinical characteristics of biphenotypic acute leukemia].
Mi Y; Bian S; Meng Q; Xue Y; Yu M; Chen G; Li D; Chen Y; Qian L
Zhonghua Xue Ye Xue Za Zhi; 2000 Jul; 21(7):352-4. PubMed ID: 11877003
[TBL] [Abstract][Full Text] [Related]
60. Acute biphenotypic leukemia in the adults.
Shen Y; Li J; Xue Y; Zhu M; Lu D; Geng M; Ruan C
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):375-7. PubMed ID: 12408768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
